Panel member characteristics
| Panel member characteristics . | Phase 1: defining competencies . | Phase 2: elaborating and validating EPAs . |
|---|---|---|
| Total no. of panel members, N | 10 | 29∗ |
| Age, mean (SD), y | 40.7 (±5.8) | 44.5 (±8.8) |
| Gender, female-to-male ratio, n | 6:4 | 16:13 |
| Geographic origin,∗ n (%) | ||
| South | 2 (20) | 6 (20.6) |
| Southeast | 5 (50) | 14 (48.2) |
| Northeast | 1 (10) | 6 (20.6) |
| Midwest | 2 (20) | 3 (10.3) |
| North | 0 | 0 |
| Years of hematology practice, n (%) | ||
| <5 | 1 (10) | 2 (6.8) |
| 5-10 | 2 (20) | 5 (17.2) |
| 10-20 | 6 (60) | 14 (48.2) |
| >20 | 1 (10) | 8 (27.5) |
| Academic degree, n (%) | ||
| MD | 10 (100) | 29 (100) |
| MD, PhD | 4 (40) | 12 (41.3) |
| Sector of hematology practice, n (%) | ||
| Public only | 3 (30) | 6 (20.6) |
| Private only | 1 (10) | 3 (10.3) |
| Public and private | 6 (60) | 20 (68.9) |
| Role in medical practice, n (%) | ||
| Preceptor of HHR† | 9 (90) | 29 (100) |
| Professor | 4 (40) | 16 (55.1) |
| Manager | 2 (20) | 10 (34.4) |
| Pharmaceutical industry | 2 (20) | 8 (27.5) |
| Private medical office | 5 (50) | 23 (79.3) |
| Public health care, except for HHR | 6 (60) | 18 (62) |
| Only HHR | 0 | 0 |
| Formal training in medical education, n (%) | 4 (40) | 13 (44.8) |
| Panel member characteristics . | Phase 1: defining competencies . | Phase 2: elaborating and validating EPAs . |
|---|---|---|
| Total no. of panel members, N | 10 | 29∗ |
| Age, mean (SD), y | 40.7 (±5.8) | 44.5 (±8.8) |
| Gender, female-to-male ratio, n | 6:4 | 16:13 |
| Geographic origin,∗ n (%) | ||
| South | 2 (20) | 6 (20.6) |
| Southeast | 5 (50) | 14 (48.2) |
| Northeast | 1 (10) | 6 (20.6) |
| Midwest | 2 (20) | 3 (10.3) |
| North | 0 | 0 |
| Years of hematology practice, n (%) | ||
| <5 | 1 (10) | 2 (6.8) |
| 5-10 | 2 (20) | 5 (17.2) |
| 10-20 | 6 (60) | 14 (48.2) |
| >20 | 1 (10) | 8 (27.5) |
| Academic degree, n (%) | ||
| MD | 10 (100) | 29 (100) |
| MD, PhD | 4 (40) | 12 (41.3) |
| Sector of hematology practice, n (%) | ||
| Public only | 3 (30) | 6 (20.6) |
| Private only | 1 (10) | 3 (10.3) |
| Public and private | 6 (60) | 20 (68.9) |
| Role in medical practice, n (%) | ||
| Preceptor of HHR† | 9 (90) | 29 (100) |
| Professor | 4 (40) | 16 (55.1) |
| Manager | 2 (20) | 10 (34.4) |
| Pharmaceutical industry | 2 (20) | 8 (27.5) |
| Private medical office | 5 (50) | 23 (79.3) |
| Public health care, except for HHR | 6 (60) | 18 (62) |
| Only HHR | 0 | 0 |
| Formal training in medical education, n (%) | 4 (40) | 13 (44.8) |